Global Celecoxib API Market Research Report 2024, Forecast to 2032
Report Overview
Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.
The global Celecoxib API market size was estimated at USD 56 million in 2023 and is projected to reach USD 86.13 million by 2032, exhibiting a CAGR of 4.90% during the forecast period.
North America Celecoxib API market size was estimated at USD 15.84 million in 2023, at a CAGR of 4.20% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Celecoxib API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Celecoxib API Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Celecoxib API market in any manner.
Global Celecoxib API Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Teva Pharmaceuticals
Viatris(Mylan)
ScinoPharm
Jiangxi Synergy
Jiangsu Hengrui Medicine
Jiangsu Chiatai Qingjiang
Hisun Pharmaceutical Nantong
Aurobindo Pharma
Punjab Chemicals
Market Segmentation (by Type)
Standard grade Celecoxib API
Micronized Celecoxib API
Market Segmentation (by Application)
Pharmaceutical
Laboratory
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celecoxib API Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Celecoxib API, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.
The global Celecoxib API market size was estimated at USD 56 million in 2023 and is projected to reach USD 86.13 million by 2032, exhibiting a CAGR of 4.90% during the forecast period.
North America Celecoxib API market size was estimated at USD 15.84 million in 2023, at a CAGR of 4.20% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Celecoxib API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Celecoxib API Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Celecoxib API market in any manner.
Global Celecoxib API Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Teva Pharmaceuticals
Viatris(Mylan)
ScinoPharm
Jiangxi Synergy
Jiangsu Hengrui Medicine
Jiangsu Chiatai Qingjiang
Hisun Pharmaceutical Nantong
Aurobindo Pharma
Punjab Chemicals
Market Segmentation (by Type)
Standard grade Celecoxib API
Micronized Celecoxib API
Market Segmentation (by Application)
Pharmaceutical
Laboratory
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Celecoxib API Market
- Overview of the regional outlook of the Celecoxib API Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celecoxib API Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Celecoxib API, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Celecoxib API
1.2 Key Market Segments
1.2.1 Celecoxib API Segment by Type
1.2.2 Celecoxib API Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELECOXIB API MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celecoxib API Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Celecoxib API Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELECOXIB API MARKET COMPETITIVE LANDSCAPE
3.1 Global Celecoxib API Sales by Manufacturers (2019-2024)
3.2 Global Celecoxib API Revenue Market Share by Manufacturers (2019-2024)
3.3 Celecoxib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Celecoxib API Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Celecoxib API Sales Sites, Area Served, Product Type
3.6 Celecoxib API Market Competitive Situation and Trends
3.6.1 Celecoxib API Market Concentration Rate
3.6.2 Global 5 and 10 Largest Celecoxib API Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELECOXIB API INDUSTRY CHAIN ANALYSIS
4.1 Celecoxib API Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELECOXIB API MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELECOXIB API MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celecoxib API Sales Market Share by Type (2019-2024)
6.3 Global Celecoxib API Market Size Market Share by Type (2019-2024)
6.4 Global Celecoxib API Price by Type (2019-2024)
7 CELECOXIB API MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celecoxib API Market Sales by Application (2019-2024)
7.3 Global Celecoxib API Market Size (M USD) by Application (2019-2024)
7.4 Global Celecoxib API Sales Growth Rate by Application (2019-2024)
8 CELECOXIB API MARKET CONSUMPTION BY REGION
8.1 Global Celecoxib API Sales by Region
8.1.1 Global Celecoxib API Sales by Region
8.1.2 Global Celecoxib API Sales Market Share by Region
8.2 North America
8.2.1 North America Celecoxib API Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Celecoxib API Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Celecoxib API Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Celecoxib API Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Celecoxib API Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 CELECOXIB API MARKET PRODUCTION BY REGION
9.1 Global Production of Celecoxib API by Region (2019-2024)
9.2 Global Celecoxib API Revenue Market Share by Region (2019-2024)
9.3 Global Celecoxib API Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Celecoxib API Production
9.4.1 North America Celecoxib API Production Growth Rate (2019-2024)
9.4.2 North America Celecoxib API Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Celecoxib API Production
9.5.1 Europe Celecoxib API Production Growth Rate (2019-2024)
9.5.2 Europe Celecoxib API Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Celecoxib API Production (2019-2024)
9.6.1 Japan Celecoxib API Production Growth Rate (2019-2024)
9.6.2 Japan Celecoxib API Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Celecoxib API Production (2019-2024)
9.7.1 China Celecoxib API Production Growth Rate (2019-2024)
9.7.2 China Celecoxib API Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Celecoxib API Basic Information
10.1.2 Pfizer Celecoxib API Product Overview
10.1.3 Pfizer Celecoxib API Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Celecoxib API SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Teva Pharmaceuticals
10.2.1 Teva Pharmaceuticals Celecoxib API Basic Information
10.2.2 Teva Pharmaceuticals Celecoxib API Product Overview
10.2.3 Teva Pharmaceuticals Celecoxib API Product Market Performance
10.2.4 Teva Pharmaceuticals Business Overview
10.2.5 Teva Pharmaceuticals Celecoxib API SWOT Analysis
10.2.6 Teva Pharmaceuticals Recent Developments
10.3 Viatris(Mylan)
10.3.1 Viatris(Mylan) Celecoxib API Basic Information
10.3.2 Viatris(Mylan) Celecoxib API Product Overview
10.3.3 Viatris(Mylan) Celecoxib API Product Market Performance
10.3.4 Viatris(Mylan) Celecoxib API SWOT Analysis
10.3.5 Viatris(Mylan) Business Overview
10.3.6 Viatris(Mylan) Recent Developments
10.4 ScinoPharm
10.4.1 ScinoPharm Celecoxib API Basic Information
10.4.2 ScinoPharm Celecoxib API Product Overview
10.4.3 ScinoPharm Celecoxib API Product Market Performance
10.4.4 ScinoPharm Business Overview
10.4.5 ScinoPharm Recent Developments
10.5 Jiangxi Synergy
10.5.1 Jiangxi Synergy Celecoxib API Basic Information
10.5.2 Jiangxi Synergy Celecoxib API Product Overview
10.5.3 Jiangxi Synergy Celecoxib API Product Market Performance
10.5.4 Jiangxi Synergy Business Overview
10.5.5 Jiangxi Synergy Recent Developments
10.6 Jiangsu Hengrui Medicine
10.6.1 Jiangsu Hengrui Medicine Celecoxib API Basic Information
10.6.2 Jiangsu Hengrui Medicine Celecoxib API Product Overview
10.6.3 Jiangsu Hengrui Medicine Celecoxib API Product Market Performance
10.6.4 Jiangsu Hengrui Medicine Business Overview
10.6.5 Jiangsu Hengrui Medicine Recent Developments
10.7 Jiangsu Chiatai Qingjiang
10.7.1 Jiangsu Chiatai Qingjiang Celecoxib API Basic Information
10.7.2 Jiangsu Chiatai Qingjiang Celecoxib API Product Overview
10.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Product Market Performance
10.7.4 Jiangsu Chiatai Qingjiang Business Overview
10.7.5 Jiangsu Chiatai Qingjiang Recent Developments
10.8 Hisun Pharmaceutical Nantong
10.8.1 Hisun Pharmaceutical Nantong Celecoxib API Basic Information
10.8.2 Hisun Pharmaceutical Nantong Celecoxib API Product Overview
10.8.3 Hisun Pharmaceutical Nantong Celecoxib API Product Market Performance
10.8.4 Hisun Pharmaceutical Nantong Business Overview
10.8.5 Hisun Pharmaceutical Nantong Recent Developments
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Celecoxib API Basic Information
10.9.2 Aurobindo Pharma Celecoxib API Product Overview
10.9.3 Aurobindo Pharma Celecoxib API Product Market Performance
10.9.4 Aurobindo Pharma Business Overview
10.9.5 Aurobindo Pharma Recent Developments
10.10 Punjab Chemicals
10.10.1 Punjab Chemicals Celecoxib API Basic Information
10.10.2 Punjab Chemicals Celecoxib API Product Overview
10.10.3 Punjab Chemicals Celecoxib API Product Market Performance
10.10.4 Punjab Chemicals Business Overview
10.10.5 Punjab Chemicals Recent Developments
11 CELECOXIB API MARKET FORECAST BY REGION
11.1 Global Celecoxib API Market Size Forecast
11.2 Global Celecoxib API Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celecoxib API Market Size Forecast by Country
11.2.3 Asia Pacific Celecoxib API Market Size Forecast by Region
11.2.4 South America Celecoxib API Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Celecoxib API by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Celecoxib API Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Celecoxib API by Type (2025-2032)
12.1.2 Global Celecoxib API Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Celecoxib API by Type (2025-2032)
12.2 Global Celecoxib API Market Forecast by Application (2025-2032)
12.2.1 Global Celecoxib API Sales (K MT) Forecast by Application
12.2.2 Global Celecoxib API Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Celecoxib API
1.2 Key Market Segments
1.2.1 Celecoxib API Segment by Type
1.2.2 Celecoxib API Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELECOXIB API MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celecoxib API Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Celecoxib API Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELECOXIB API MARKET COMPETITIVE LANDSCAPE
3.1 Global Celecoxib API Sales by Manufacturers (2019-2024)
3.2 Global Celecoxib API Revenue Market Share by Manufacturers (2019-2024)
3.3 Celecoxib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Celecoxib API Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Celecoxib API Sales Sites, Area Served, Product Type
3.6 Celecoxib API Market Competitive Situation and Trends
3.6.1 Celecoxib API Market Concentration Rate
3.6.2 Global 5 and 10 Largest Celecoxib API Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELECOXIB API INDUSTRY CHAIN ANALYSIS
4.1 Celecoxib API Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELECOXIB API MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELECOXIB API MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celecoxib API Sales Market Share by Type (2019-2024)
6.3 Global Celecoxib API Market Size Market Share by Type (2019-2024)
6.4 Global Celecoxib API Price by Type (2019-2024)
7 CELECOXIB API MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celecoxib API Market Sales by Application (2019-2024)
7.3 Global Celecoxib API Market Size (M USD) by Application (2019-2024)
7.4 Global Celecoxib API Sales Growth Rate by Application (2019-2024)
8 CELECOXIB API MARKET CONSUMPTION BY REGION
8.1 Global Celecoxib API Sales by Region
8.1.1 Global Celecoxib API Sales by Region
8.1.2 Global Celecoxib API Sales Market Share by Region
8.2 North America
8.2.1 North America Celecoxib API Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Celecoxib API Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Celecoxib API Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Celecoxib API Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Celecoxib API Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 CELECOXIB API MARKET PRODUCTION BY REGION
9.1 Global Production of Celecoxib API by Region (2019-2024)
9.2 Global Celecoxib API Revenue Market Share by Region (2019-2024)
9.3 Global Celecoxib API Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Celecoxib API Production
9.4.1 North America Celecoxib API Production Growth Rate (2019-2024)
9.4.2 North America Celecoxib API Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Celecoxib API Production
9.5.1 Europe Celecoxib API Production Growth Rate (2019-2024)
9.5.2 Europe Celecoxib API Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Celecoxib API Production (2019-2024)
9.6.1 Japan Celecoxib API Production Growth Rate (2019-2024)
9.6.2 Japan Celecoxib API Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Celecoxib API Production (2019-2024)
9.7.1 China Celecoxib API Production Growth Rate (2019-2024)
9.7.2 China Celecoxib API Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Celecoxib API Basic Information
10.1.2 Pfizer Celecoxib API Product Overview
10.1.3 Pfizer Celecoxib API Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Celecoxib API SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Teva Pharmaceuticals
10.2.1 Teva Pharmaceuticals Celecoxib API Basic Information
10.2.2 Teva Pharmaceuticals Celecoxib API Product Overview
10.2.3 Teva Pharmaceuticals Celecoxib API Product Market Performance
10.2.4 Teva Pharmaceuticals Business Overview
10.2.5 Teva Pharmaceuticals Celecoxib API SWOT Analysis
10.2.6 Teva Pharmaceuticals Recent Developments
10.3 Viatris(Mylan)
10.3.1 Viatris(Mylan) Celecoxib API Basic Information
10.3.2 Viatris(Mylan) Celecoxib API Product Overview
10.3.3 Viatris(Mylan) Celecoxib API Product Market Performance
10.3.4 Viatris(Mylan) Celecoxib API SWOT Analysis
10.3.5 Viatris(Mylan) Business Overview
10.3.6 Viatris(Mylan) Recent Developments
10.4 ScinoPharm
10.4.1 ScinoPharm Celecoxib API Basic Information
10.4.2 ScinoPharm Celecoxib API Product Overview
10.4.3 ScinoPharm Celecoxib API Product Market Performance
10.4.4 ScinoPharm Business Overview
10.4.5 ScinoPharm Recent Developments
10.5 Jiangxi Synergy
10.5.1 Jiangxi Synergy Celecoxib API Basic Information
10.5.2 Jiangxi Synergy Celecoxib API Product Overview
10.5.3 Jiangxi Synergy Celecoxib API Product Market Performance
10.5.4 Jiangxi Synergy Business Overview
10.5.5 Jiangxi Synergy Recent Developments
10.6 Jiangsu Hengrui Medicine
10.6.1 Jiangsu Hengrui Medicine Celecoxib API Basic Information
10.6.2 Jiangsu Hengrui Medicine Celecoxib API Product Overview
10.6.3 Jiangsu Hengrui Medicine Celecoxib API Product Market Performance
10.6.4 Jiangsu Hengrui Medicine Business Overview
10.6.5 Jiangsu Hengrui Medicine Recent Developments
10.7 Jiangsu Chiatai Qingjiang
10.7.1 Jiangsu Chiatai Qingjiang Celecoxib API Basic Information
10.7.2 Jiangsu Chiatai Qingjiang Celecoxib API Product Overview
10.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Product Market Performance
10.7.4 Jiangsu Chiatai Qingjiang Business Overview
10.7.5 Jiangsu Chiatai Qingjiang Recent Developments
10.8 Hisun Pharmaceutical Nantong
10.8.1 Hisun Pharmaceutical Nantong Celecoxib API Basic Information
10.8.2 Hisun Pharmaceutical Nantong Celecoxib API Product Overview
10.8.3 Hisun Pharmaceutical Nantong Celecoxib API Product Market Performance
10.8.4 Hisun Pharmaceutical Nantong Business Overview
10.8.5 Hisun Pharmaceutical Nantong Recent Developments
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Celecoxib API Basic Information
10.9.2 Aurobindo Pharma Celecoxib API Product Overview
10.9.3 Aurobindo Pharma Celecoxib API Product Market Performance
10.9.4 Aurobindo Pharma Business Overview
10.9.5 Aurobindo Pharma Recent Developments
10.10 Punjab Chemicals
10.10.1 Punjab Chemicals Celecoxib API Basic Information
10.10.2 Punjab Chemicals Celecoxib API Product Overview
10.10.3 Punjab Chemicals Celecoxib API Product Market Performance
10.10.4 Punjab Chemicals Business Overview
10.10.5 Punjab Chemicals Recent Developments
11 CELECOXIB API MARKET FORECAST BY REGION
11.1 Global Celecoxib API Market Size Forecast
11.2 Global Celecoxib API Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celecoxib API Market Size Forecast by Country
11.2.3 Asia Pacific Celecoxib API Market Size Forecast by Region
11.2.4 South America Celecoxib API Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Celecoxib API by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Celecoxib API Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Celecoxib API by Type (2025-2032)
12.1.2 Global Celecoxib API Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Celecoxib API by Type (2025-2032)
12.2 Global Celecoxib API Market Forecast by Application (2025-2032)
12.2.1 Global Celecoxib API Sales (K MT) Forecast by Application
12.2.2 Global Celecoxib API Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Celecoxib API Market Size Comparison by Region (M USD)
Table 5. Global Celecoxib API Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Celecoxib API Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Celecoxib API Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Celecoxib API Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib API as of 2022)
Table 10. Global Market Celecoxib API Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Celecoxib API Sales Sites and Area Served
Table 12. Manufacturers Celecoxib API Product Type
Table 13. Global Celecoxib API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Celecoxib API
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celecoxib API Market Challenges
Table 22. Global Celecoxib API Sales by Type (K MT)
Table 23. Global Celecoxib API Market Size by Type (M USD)
Table 24. Global Celecoxib API Sales (K MT) by Type (2019-2024)
Table 25. Global Celecoxib API Sales Market Share by Type (2019-2024)
Table 26. Global Celecoxib API Market Size (M USD) by Type (2019-2024)
Table 27. Global Celecoxib API Market Size Share by Type (2019-2024)
Table 28. Global Celecoxib API Price (USD/MT) by Type (2019-2024)
Table 29. Global Celecoxib API Sales (K MT) by Application
Table 30. Global Celecoxib API Market Size by Application
Table 31. Global Celecoxib API Sales by Application (2019-2024) & (K MT)
Table 32. Global Celecoxib API Sales Market Share by Application (2019-2024)
Table 33. Global Celecoxib API Sales by Application (2019-2024) & (M USD)
Table 34. Global Celecoxib API Market Share by Application (2019-2024)
Table 35. Global Celecoxib API Sales Growth Rate by Application (2019-2024)
Table 36. Global Celecoxib API Sales by Region (2019-2024) & (K MT)
Table 37. Global Celecoxib API Sales Market Share by Region (2019-2024)
Table 38. North America Celecoxib API Sales by Country (2019-2024) & (K MT)
Table 39. Europe Celecoxib API Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Celecoxib API Sales by Region (2019-2024) & (K MT)
Table 41. South America Celecoxib API Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Celecoxib API Sales by Region (2019-2024) & (K MT)
Table 43. Global Celecoxib API Production (K MT) by Region (2019-2024)
Table 44. Global Celecoxib API Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Celecoxib API Revenue Market Share by Region (2019-2024)
Table 46. Global Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Pfizer Celecoxib API Basic Information
Table 52. Pfizer Celecoxib API Product Overview
Table 53. Pfizer Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Pfizer Business Overview
Table 55. Pfizer Celecoxib API SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Teva Pharmaceuticals Celecoxib API Basic Information
Table 58. Teva Pharmaceuticals Celecoxib API Product Overview
Table 59. Teva Pharmaceuticals Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Teva Pharmaceuticals Business Overview
Table 61. Teva Pharmaceuticals Celecoxib API SWOT Analysis
Table 62. Teva Pharmaceuticals Recent Developments
Table 63. Viatris(Mylan) Celecoxib API Basic Information
Table 64. Viatris(Mylan) Celecoxib API Product Overview
Table 65. Viatris(Mylan) Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Viatris(Mylan) Celecoxib API SWOT Analysis
Table 67. Viatris(Mylan) Business Overview
Table 68. Viatris(Mylan) Recent Developments
Table 69. ScinoPharm Celecoxib API Basic Information
Table 70. ScinoPharm Celecoxib API Product Overview
Table 71. ScinoPharm Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. ScinoPharm Business Overview
Table 73. ScinoPharm Recent Developments
Table 74. Jiangxi Synergy Celecoxib API Basic Information
Table 75. Jiangxi Synergy Celecoxib API Product Overview
Table 76. Jiangxi Synergy Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Jiangxi Synergy Business Overview
Table 78. Jiangxi Synergy Recent Developments
Table 79. Jiangsu Hengrui Medicine Celecoxib API Basic Information
Table 80. Jiangsu Hengrui Medicine Celecoxib API Product Overview
Table 81. Jiangsu Hengrui Medicine Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Jiangsu Hengrui Medicine Business Overview
Table 83. Jiangsu Hengrui Medicine Recent Developments
Table 84. Jiangsu Chiatai Qingjiang Celecoxib API Basic Information
Table 85. Jiangsu Chiatai Qingjiang Celecoxib API Product Overview
Table 86. Jiangsu Chiatai Qingjiang Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Jiangsu Chiatai Qingjiang Business Overview
Table 88. Jiangsu Chiatai Qingjiang Recent Developments
Table 89. Hisun Pharmaceutical Nantong Celecoxib API Basic Information
Table 90. Hisun Pharmaceutical Nantong Celecoxib API Product Overview
Table 91. Hisun Pharmaceutical Nantong Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Hisun Pharmaceutical Nantong Business Overview
Table 93. Hisun Pharmaceutical Nantong Recent Developments
Table 94. Aurobindo Pharma Celecoxib API Basic Information
Table 95. Aurobindo Pharma Celecoxib API Product Overview
Table 96. Aurobindo Pharma Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Aurobindo Pharma Business Overview
Table 98. Aurobindo Pharma Recent Developments
Table 99. Punjab Chemicals Celecoxib API Basic Information
Table 100. Punjab Chemicals Celecoxib API Product Overview
Table 101. Punjab Chemicals Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Punjab Chemicals Business Overview
Table 103. Punjab Chemicals Recent Developments
Table 104. Global Celecoxib API Sales Forecast by Region (2025-2032) & (K MT)
Table 105. Global Celecoxib API Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Celecoxib API Sales Forecast by Country (2025-2032) & (K MT)
Table 107. North America Celecoxib API Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Celecoxib API Sales Forecast by Country (2025-2032) & (K MT)
Table 109. Europe Celecoxib API Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Celecoxib API Sales Forecast by Region (2025-2032) & (K MT)
Table 111. Asia Pacific Celecoxib API Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Celecoxib API Sales Forecast by Country (2025-2032) & (K MT)
Table 113. South America Celecoxib API Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Celecoxib API Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Celecoxib API Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Celecoxib API Sales Forecast by Type (2025-2032) & (K MT)
Table 117. Global Celecoxib API Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Celecoxib API Price Forecast by Type (2025-2032) & (USD/MT)
Table 119. Global Celecoxib API Sales (K MT) Forecast by Application (2025-2032)
Table 120. Global Celecoxib API Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Celecoxib API Market Size Comparison by Region (M USD)
Table 5. Global Celecoxib API Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Celecoxib API Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Celecoxib API Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Celecoxib API Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib API as of 2022)
Table 10. Global Market Celecoxib API Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Celecoxib API Sales Sites and Area Served
Table 12. Manufacturers Celecoxib API Product Type
Table 13. Global Celecoxib API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Celecoxib API
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celecoxib API Market Challenges
Table 22. Global Celecoxib API Sales by Type (K MT)
Table 23. Global Celecoxib API Market Size by Type (M USD)
Table 24. Global Celecoxib API Sales (K MT) by Type (2019-2024)
Table 25. Global Celecoxib API Sales Market Share by Type (2019-2024)
Table 26. Global Celecoxib API Market Size (M USD) by Type (2019-2024)
Table 27. Global Celecoxib API Market Size Share by Type (2019-2024)
Table 28. Global Celecoxib API Price (USD/MT) by Type (2019-2024)
Table 29. Global Celecoxib API Sales (K MT) by Application
Table 30. Global Celecoxib API Market Size by Application
Table 31. Global Celecoxib API Sales by Application (2019-2024) & (K MT)
Table 32. Global Celecoxib API Sales Market Share by Application (2019-2024)
Table 33. Global Celecoxib API Sales by Application (2019-2024) & (M USD)
Table 34. Global Celecoxib API Market Share by Application (2019-2024)
Table 35. Global Celecoxib API Sales Growth Rate by Application (2019-2024)
Table 36. Global Celecoxib API Sales by Region (2019-2024) & (K MT)
Table 37. Global Celecoxib API Sales Market Share by Region (2019-2024)
Table 38. North America Celecoxib API Sales by Country (2019-2024) & (K MT)
Table 39. Europe Celecoxib API Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Celecoxib API Sales by Region (2019-2024) & (K MT)
Table 41. South America Celecoxib API Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Celecoxib API Sales by Region (2019-2024) & (K MT)
Table 43. Global Celecoxib API Production (K MT) by Region (2019-2024)
Table 44. Global Celecoxib API Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Celecoxib API Revenue Market Share by Region (2019-2024)
Table 46. Global Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Celecoxib API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Pfizer Celecoxib API Basic Information
Table 52. Pfizer Celecoxib API Product Overview
Table 53. Pfizer Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Pfizer Business Overview
Table 55. Pfizer Celecoxib API SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Teva Pharmaceuticals Celecoxib API Basic Information
Table 58. Teva Pharmaceuticals Celecoxib API Product Overview
Table 59. Teva Pharmaceuticals Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Teva Pharmaceuticals Business Overview
Table 61. Teva Pharmaceuticals Celecoxib API SWOT Analysis
Table 62. Teva Pharmaceuticals Recent Developments
Table 63. Viatris(Mylan) Celecoxib API Basic Information
Table 64. Viatris(Mylan) Celecoxib API Product Overview
Table 65. Viatris(Mylan) Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Viatris(Mylan) Celecoxib API SWOT Analysis
Table 67. Viatris(Mylan) Business Overview
Table 68. Viatris(Mylan) Recent Developments
Table 69. ScinoPharm Celecoxib API Basic Information
Table 70. ScinoPharm Celecoxib API Product Overview
Table 71. ScinoPharm Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. ScinoPharm Business Overview
Table 73. ScinoPharm Recent Developments
Table 74. Jiangxi Synergy Celecoxib API Basic Information
Table 75. Jiangxi Synergy Celecoxib API Product Overview
Table 76. Jiangxi Synergy Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Jiangxi Synergy Business Overview
Table 78. Jiangxi Synergy Recent Developments
Table 79. Jiangsu Hengrui Medicine Celecoxib API Basic Information
Table 80. Jiangsu Hengrui Medicine Celecoxib API Product Overview
Table 81. Jiangsu Hengrui Medicine Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Jiangsu Hengrui Medicine Business Overview
Table 83. Jiangsu Hengrui Medicine Recent Developments
Table 84. Jiangsu Chiatai Qingjiang Celecoxib API Basic Information
Table 85. Jiangsu Chiatai Qingjiang Celecoxib API Product Overview
Table 86. Jiangsu Chiatai Qingjiang Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Jiangsu Chiatai Qingjiang Business Overview
Table 88. Jiangsu Chiatai Qingjiang Recent Developments
Table 89. Hisun Pharmaceutical Nantong Celecoxib API Basic Information
Table 90. Hisun Pharmaceutical Nantong Celecoxib API Product Overview
Table 91. Hisun Pharmaceutical Nantong Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Hisun Pharmaceutical Nantong Business Overview
Table 93. Hisun Pharmaceutical Nantong Recent Developments
Table 94. Aurobindo Pharma Celecoxib API Basic Information
Table 95. Aurobindo Pharma Celecoxib API Product Overview
Table 96. Aurobindo Pharma Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Aurobindo Pharma Business Overview
Table 98. Aurobindo Pharma Recent Developments
Table 99. Punjab Chemicals Celecoxib API Basic Information
Table 100. Punjab Chemicals Celecoxib API Product Overview
Table 101. Punjab Chemicals Celecoxib API Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Punjab Chemicals Business Overview
Table 103. Punjab Chemicals Recent Developments
Table 104. Global Celecoxib API Sales Forecast by Region (2025-2032) & (K MT)
Table 105. Global Celecoxib API Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Celecoxib API Sales Forecast by Country (2025-2032) & (K MT)
Table 107. North America Celecoxib API Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Celecoxib API Sales Forecast by Country (2025-2032) & (K MT)
Table 109. Europe Celecoxib API Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Celecoxib API Sales Forecast by Region (2025-2032) & (K MT)
Table 111. Asia Pacific Celecoxib API Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Celecoxib API Sales Forecast by Country (2025-2032) & (K MT)
Table 113. South America Celecoxib API Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Celecoxib API Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Celecoxib API Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Celecoxib API Sales Forecast by Type (2025-2032) & (K MT)
Table 117. Global Celecoxib API Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Celecoxib API Price Forecast by Type (2025-2032) & (USD/MT)
Table 119. Global Celecoxib API Sales (K MT) Forecast by Application (2025-2032)
Table 120. Global Celecoxib API Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Celecoxib API
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celecoxib API Market Size (M USD), 2019-2032
Figure 5. Global Celecoxib API Market Size (M USD) (2019-2032)
Figure 6. Global Celecoxib API Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celecoxib API Market Size by Country (M USD)
Figure 11. Celecoxib API Sales Share by Manufacturers in 2023
Figure 12. Global Celecoxib API Revenue Share by Manufacturers in 2023
Figure 13. Celecoxib API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Celecoxib API Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Celecoxib API Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Celecoxib API Market Share by Type
Figure 18. Sales Market Share of Celecoxib API by Type (2019-2024)
Figure 19. Sales Market Share of Celecoxib API by Type in 2023
Figure 20. Market Size Share of Celecoxib API by Type (2019-2024)
Figure 21. Market Size Market Share of Celecoxib API by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Celecoxib API Market Share by Application
Figure 24. Global Celecoxib API Sales Market Share by Application (2019-2024)
Figure 25. Global Celecoxib API Sales Market Share by Application in 2023
Figure 26. Global Celecoxib API Market Share by Application (2019-2024)
Figure 27. Global Celecoxib API Market Share by Application in 2023
Figure 28. Global Celecoxib API Sales Growth Rate by Application (2019-2024)
Figure 29. Global Celecoxib API Sales Market Share by Region (2019-2024)
Figure 30. North America Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Celecoxib API Sales Market Share by Country in 2023
Figure 32. U.S. Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Celecoxib API Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Celecoxib API Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Celecoxib API Sales Market Share by Country in 2023
Figure 37. Germany Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Celecoxib API Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Celecoxib API Sales Market Share by Region in 2023
Figure 44. China Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Celecoxib API Sales and Growth Rate (K MT)
Figure 50. South America Celecoxib API Sales Market Share by Country in 2023
Figure 51. Brazil Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Celecoxib API Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Celecoxib API Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Celecoxib API Production Market Share by Region (2019-2024)
Figure 62. North America Celecoxib API Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Celecoxib API Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Celecoxib API Production (K MT) Growth Rate (2019-2024)
Figure 65. China Celecoxib API Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Celecoxib API Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Celecoxib API Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Celecoxib API Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Celecoxib API Market Share Forecast by Type (2025-2032)
Figure 70. Global Celecoxib API Sales Forecast by Application (2025-2032)
Figure 71. Global Celecoxib API Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Celecoxib API
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celecoxib API Market Size (M USD), 2019-2032
Figure 5. Global Celecoxib API Market Size (M USD) (2019-2032)
Figure 6. Global Celecoxib API Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celecoxib API Market Size by Country (M USD)
Figure 11. Celecoxib API Sales Share by Manufacturers in 2023
Figure 12. Global Celecoxib API Revenue Share by Manufacturers in 2023
Figure 13. Celecoxib API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Celecoxib API Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Celecoxib API Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Celecoxib API Market Share by Type
Figure 18. Sales Market Share of Celecoxib API by Type (2019-2024)
Figure 19. Sales Market Share of Celecoxib API by Type in 2023
Figure 20. Market Size Share of Celecoxib API by Type (2019-2024)
Figure 21. Market Size Market Share of Celecoxib API by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Celecoxib API Market Share by Application
Figure 24. Global Celecoxib API Sales Market Share by Application (2019-2024)
Figure 25. Global Celecoxib API Sales Market Share by Application in 2023
Figure 26. Global Celecoxib API Market Share by Application (2019-2024)
Figure 27. Global Celecoxib API Market Share by Application in 2023
Figure 28. Global Celecoxib API Sales Growth Rate by Application (2019-2024)
Figure 29. Global Celecoxib API Sales Market Share by Region (2019-2024)
Figure 30. North America Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Celecoxib API Sales Market Share by Country in 2023
Figure 32. U.S. Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Celecoxib API Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Celecoxib API Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Celecoxib API Sales Market Share by Country in 2023
Figure 37. Germany Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Celecoxib API Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Celecoxib API Sales Market Share by Region in 2023
Figure 44. China Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Celecoxib API Sales and Growth Rate (K MT)
Figure 50. South America Celecoxib API Sales Market Share by Country in 2023
Figure 51. Brazil Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Celecoxib API Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Celecoxib API Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Celecoxib API Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Celecoxib API Production Market Share by Region (2019-2024)
Figure 62. North America Celecoxib API Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Celecoxib API Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Celecoxib API Production (K MT) Growth Rate (2019-2024)
Figure 65. China Celecoxib API Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Celecoxib API Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Celecoxib API Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Celecoxib API Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Celecoxib API Market Share Forecast by Type (2025-2032)
Figure 70. Global Celecoxib API Sales Forecast by Application (2025-2032)
Figure 71. Global Celecoxib API Market Share Forecast by Application (2025-2032)
